Skip to content

Evaluation of pericapsular nerve group block for analgesic effect in elderly patients undergoing hip arthroplasty

Evaluation of pericapsular nerve group block for analgesic effect in elderly patients undergoing hip arthroplasty

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046785
Enrollment
Unknown
Registered
2021-05-28
Start date
2021-05-31
Completion date
Unknown
Last updated
2022-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip surgery

Interventions

PENG group:20ml of 0.4% ropivacaine was injected into the peripheral nerve of the hip capsule under ultrasound guidance
FICB group:Ultrasound guided injection of 30ml 0.4% ropivacaine into the iliac fascial space around the nerve

Sponsors

Wuxi 9th Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.Unilateral osteonecrosis of the femoral head and chronic hip pain were associated with joint dysfunction, and conservative treatment was ineffective, with indications for hip arthroplasty; 2.Unilateral fractures of femoral neck and trochanter, which are to be treated with internal fixation or joint replacement; 3.Aged over 60 years; 4.Preoperative grade II or above of American Society of Anesthesiologists (ASA); 5.Patients agreed before operation and signed the informed consent form; 6.All the operations were performed by doctors with senior seniority and professional title or above; 7.Able to understand and complete the visual analog scale of pain; 8.Can cooperate with functional exercisers after surgery.

Exclusion criteria

Exclusion criteria: 1.Patients have a history of dependence on or allergy to narcotic drugs or analgesics; 3.Patients with neuropsychiatric diseases in the past; 4.Peripheral neuropathy; 5.Blocking infection around the site; 6.Morbid obesity (body mass index BMI > 40kg/m^2).

Design outcomes

Primary

MeasureTime frame
Perioperative hemodynamic changes;Blood pressure;Heart rate;Saturation of pulse oximetry;

Countries

China

Contacts

Public ContactHua Hao

Wuxi 9th Affiliated Hospital of Soochow University

55699359@qq.com+86 15861577570

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026